- Incretin therapy: cardiovascular risk reduction2012 | Second Faculty of Medicine
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk reduction2015 | First Faculty of Medicine
- Results of a multifactor cardiovascular risk reduction program in the Czech Republic: The Healthy Dubec Project2000 | Third Faculty of Medicine
- EMPA-REG OUTCOME: First study whch showed cardiovascular risk reduction in type 2 diabetic patients2015 | First Faculty of Medicine
- Prevention of cardiovascular diseases in clinical practice: is it possible to achieve improvement?2014 | First Faculty of Medicine
- Implementation of Cardiovascular Disease Prevention Guidelines into Clinical Practice: an Unmet Challenge?2015 | First Faculty of Medicine
- A comprehensive guidelines-based approach reduces cardiovascular risk in everyday practice: the VARO study2017 | First Faculty of Medicine
- Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial2013 | First Faculty of Medicine
- Treatment of diabetic dyslipidaemia2013 | First Faculty of Medicine
- Do we use statins enough? News in the combination treatment by statins and ezetimibe2016 | Faculty of Medicine in Pilsen
- The different properties of sulfonamid diuretics: Get to know the quality affects the rational selection2015 | First Faculty of Medicine
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Ezetimibe/atorvastatin - new combination of lipid-modifying drugs2017 | Faculty of Medicine in Pilsen
- The antihypertensive effects of incretin therapy in type 2 diabetes mellitus2013 | First Faculty of Medicine
- Does "LDL hypothesis" also apply to patients with diabetes?2015 | Second Faculty of Medicine
- Diabetes, Lipids, and CV Risk2021 | First Faculty of Medicine
- Treatment of Hypertriglyceridemia: a Review of Current Options2015 | First Faculty of Medicine
- Chromium Supplementation Reduces Resting Heart Rate in Patients with Metabolic Syndrome and Impaired Glucose Tolerance2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Uricemia in the acute phase of myocardial infarction and its relation to long-term mortality risk2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen